SB 24 revises Maryland's Public Access Automated External Defibrillator (AED) Program to improve oversight and accessibility. It requires most organizations using public AEDs to appoint an AED coordinator responsible for maintenance, reporting, and emergency notification, while exempting law enforcement agencies from needing certificates for AEDs in patrol vehicles. The bill also repeals outdated requirements for regional AED committees and clarifies that grocery stores and restaurants are not subject to certain AED registration rules. These changes aim to streamline compliance for entities managing public AEDs, including schools, businesses, and public facilities.
HB 276 revises Maryland's Public Access Automated External Defibrillator (AED) Program to clarify requirements for entities using AEDs. It establishes a mandatory "AED Coordinator" role to maintain AED functionality and reporting, repeals outdated requirements for regional council AED committees, and exempts law enforcement agencies from needing a certificate for AEDs deployed in patrol vehicles. The bill affects businesses, organizations, and government entities that operate public AEDs, requiring them to maintain written AED plans and coordinate with emergency services. Key changes streamline oversight while ensuring AEDs remain accessible and properly maintained for public use during cardiac emergencies.
SB 205 codifies federal mental health parity requirements into Maryland law, requiring health insurance carriers to comply with the Paul Wellstone and Pete Domenici Mental Health Parity Act. It mandates carriers to collect and report data on access to mental health and substance use disorder benefits, explain differences in care access, and undergo comparative analyses of nonquantitative treatment limitations. The Maryland Insurance Commissioner gains authority to review carrier reports and address noncompliance. This bill directly affects all health insurance carriers operating in Maryland, ensuring their coverage aligns with federal parity standards for mental health and substance use disorder benefits. It clarifies enforcement mechanisms without creating new benefit requirements.
HB 280 codifies Maryland’s health insurance requirements for mental health and substance use disorder coverage to align with federal parity laws. It requires health insurers to collect and report data on access to these services, explain differences in coverage rules, and comply with federal standards for equal treatment. The Maryland Insurance Commissioner will review insurer reports and address noncompliance. This bill directly affects health insurance companies and their policyholders seeking mental health or substance use disorder care.
HB 278, the "Longevity Ready Maryland Act," requires Maryland's Secretary of Aging to lead implementation of the Longevity Ready Maryland Plan. This plan aims to coordinate state services for older adults by evaluating their needs, assessing existing programs, and fostering cross-sector collaboration across health, housing, employment, and social services. The bill mandates annual reports to the governor and legislature on progress, updates the Commission on Aging's role, and requires a comprehensive statewide plan to be revised every four years. It directly affects older Marylanders, the Department of Aging, local area agencies on aging, and state agencies responsible for aging-related services.
HB 393 requires health insurers, nonprofit health plans, HMOs, and managed care organizations in Maryland to cover scalp cooling systems when they provide coverage for chemotherapy treatments for cancer. This applies directly to cancer patients undergoing chemotherapy who use scalp cooling to prevent hair loss, and to the insurers that must now include this coverage. The bill defines scalp cooling systems as medical devices designed for repeated use to preserve hair during cancer treatment. Coverage must be provided for these systems as part of chemotherapy treatment plans, effective January 1, 2027. The law amends Maryland’s Insurance Article (Section 15-864) to mandate this coverage for qualifying health plans.
SB 385 (The Vax Act) requires Maryland’s Secretary of Health to issue evidence-based recommendations for immunizations, screenings, and preventive services, aligning with guidance from major medical organizations like the CDC and U.S. Preventive Services Task Force. It expands pharmacists’ authority to administer vaccines (including those recommended by CDC or the Secretary) to patients aged 3+ after completing specific training and certification, while mandating health insurers to cover these services without cost-sharing. The bill also repeals outdated pertussis-related provisions and updates reporting requirements for pharmacists. This directly affects pharmacists, health insurers, and patients seeking preventive care, aiming to improve access to vaccinations and screenings.
HB 637 ("The Vax Act") requires Maryland's Secretary of Health to issue science-based recommendations for immunizations, screenings, and preventive services using guidance from major medical organizations like the CDC and American Academy of Pediatrics. It expands pharmacists' authority to administer flu, COVID-19, and emergency vaccines to patients aged 3 and older (previously limited to 18+ for some vaccines) after completing specific training. The bill also mandates that health insurance plans cover these recommended services without cost-sharing for patients. This directly affects pharmacists, health insurers, and Maryland residents seeking preventive care, particularly children and adults needing routine vaccinations.
HB 498 removes an existing exemption that allowed intermediate care facilities providing substance use disorder treatment to change bed capacity without a certificate of need. It specifically targets facilities offering "medically managed residential substance use disorder treatment services," requiring them to file 45 days' written notice with the health commission before operating or expanding. The commission must then review and approve these changes based on whether they align with the state health plan, improve service efficiency, and serve the public interest. This bill directly affects facilities providing residential substance use treatment by adding a review process for bed capacity changes or new operations, replacing the previous exemption.
HB 797 prohibits employers from discriminating against fire and rescue public safety employees who use medical cannabis, provided they have a valid written certification from a licensed healthcare provider under Maryland's medical cannabis program. The bill modifies existing law to clarify that an employer cannot take adverse employment actions (like termination or denial of promotion) solely due to medical cannabis use, as long as the employee meets the state's certification requirements. It updates definitions in Maryland law to ensure fire and rescue employees qualify for the same protections as other medical cannabis patients under the existing program. The law does not override workplace safety rules or require employers to accommodate cannabis use during work hours.
